Juno Therapeutics

Read more

JUNO THERAPEUTICS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

bluebird bio is the top competitor of Juno Therapeutics. bluebird bio was founded in 1992, and its headquarters is in Cambridge, Massachusetts. Like Juno Therapeutics, bluebird bio also operates in the Biotechnology field. bluebird bio has 550 more employees than Juno Therapeutics.

Celgene is seen as one of Juno Therapeutics's top competitors. Celgene was founded in Summit, New Jersey} in 1986. Like Juno Therapeutics, Celgene also works within the Biotechnology field. Compared to Juno Therapeutics, Celgene generates $15.2B more revenue.

Kite Pharma is Juno Therapeutics's #3 rival. Kite Pharma's headquarters is in Santa Monica, California, and was founded in 2009. Like Juno Therapeutics, Kite Pharma also operates in the Biotechnology sector. Kite Pharma generates 42% of Juno Therapeutics's revenue.

Juno Therapeutics Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

RedoxTherapies, Inc

Jul 2016

Source »
undisclosed
-
Abvitro, Inc.

Jan 2016

Source »
$78M
AbVitro is an immuno-oncology antibody discovery platform that allows for the discovery of cancer specific tumor infiltrating lymphocytes.
X-BODY Biosciences, Inc.

Jun 2015

Source »
$21M
X-BODY Biosciences is a biotechnology firm that focuses on discovery of monoclonal antibodies against novel therapeutic.

These are all the companies that Juno Therapeutics has acquired. Juno Therapeutics has acquired 3 companies and its latest acquisition was RedoxTherapies, Inc in Jul 2016.

Juno Therapeutics Funding History

Since Juno Therapeutics was founded in 2013, it has participated in 6 rounds of funding. In total Juno Therapeutics has raised $1.5B. Juno Therapeutics' last funding round was on Sep 2017 for a total of $31.1M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Sep 2017
$31.1M
Equity
Jun 2015
$896.8M

Venrock

IPO
Dec 2014
$264.6M
-
Series B
Jul 2014
$134M
Series A
Apr 2014
$176M

Since Juno Therapeutics was founded in 2013, it has participated in 6 rounds of funding. In total Juno Therapeutics has raised $1.5B. Juno Therapeutics' last funding round was on Sep 2017 for a total of $31.1M

Juno Therapeutics Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

JW Therapeutics is a biopharmaceutical company that develops and commercializes cell-based immunotherapies for the treatment of cancer.
$100M
Jun 09, 2020
Series B
Nov 03, 2020
JW Therapeutics is a biopharmaceutical company that develops and commercializes cell-based immunotherapies for the treatment of cancer.
$90M
Mar 07, 2018
Series A
Nov 03, 2020

These are all the companies that Juno Therapeutics has invested in. Juno Therapeutics has invested 2 companies and its latest investment was JW Therapeutics in Jun 09,. JW Therapeutics is a biopharmaceutical company that develops and commercializes cell-based immunotherapies for the treatment of cancer.

Juno Therapeutics News

Juno Therapeutics Press Releases

Juno Therapeutics Videos

Social Media

Juno Therapeutics Headquarters

400 Dexter Avenue North Suite 1200

Seattle, Washington98109

206-582-1600

Driving Directions »

Trending Companies

Juno Therapeutics Summary

ABOUT

Overview

Juno is a biopharmaceutical company that researches and develops cellular immunotherapies for the treatment of cancer. Juno Therapeutics was founded in 2013. Juno Therapeutics' headquarters is located in Seattle, Washington, USA 98109. It has raised 1...

Frequently Asked Questions about Juno Therapeutics

  1. When was Juno Therapeutics founded?

    Juno Therapeutics was founded in 2013
  2. How much revenue does Juno Therapeutics generate?

    Juno Therapeutics generates $106M in revenue
  3. How much funding does Juno Therapeutics have?

    Juno Therapeutics has historically raised $1.5B in funding
  4. Where is Juno Therapeutics's headquarters?

    Juno Therapeutics's headquarters is in Seattle Washington, USA
  1. How many employees does Juno Therapeutics have?

    Juno Therapeutics has 663 employees
  2. What sector does Juno Therapeutics operate in?

    Juno Therapeutics is in Biotechnology, Pharmaceuticals
  3. Who are Juno Therapeutics's competitors?

    Juno Therapeutics's top competitors are bluebird bio, Celgene, Kite Pharma
  4. Who has Juno Therapeutics invested in?

    Juno Therapeutics's has invested in companies such as JW Therapeutics, JW Therapeutics